Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05705518 · ClinicalTrials.gov registry record · Phase 4
Artificial Tears, Tear Lipids and Tear Film Dynamics
A Phase 4 study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT05705518 is a Phase 4 study that has completed, run by University of California, Berkeley. The registered enrollment target is 81 participants.
The verdict
NCT05705518, a Phase 4 study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
Dry eye disease (DED) is pervasive with some reports estimating over 16 million adults diagnosed in the United States. Currently, artificial tears remain an integral part of managing dry eyes and are mainly used for symptomatic relief. Recent studies have shown there may be therapeutic benefits with regular use of lipid-based artificial tears to improve the structure of the tear film, which may improve tear film stability and provide relief of symptoms. In this study the investigators propose to compare effects on the tear lipid film and its dynamics between 3 lipid based artificial tears and a widely available non-lipid based artificial tear.
Interventions
- DRUG Systane Complete PF
- DRUG Refresh Relieva PF
- DRUG Refresh Optive Mega-3 PF
- DRUG CVS Health Lubricant Eye Drop (PG 0.6%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2023-01-30 |
| Est. Completion | 2024-01-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05705518
The ClinicalTrials.gov registry entry for NCT05705518 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Systane Complete PF is the first listed.
NCT05705518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05705518 about?
NCT05705518 is a clinical study titled "Artificial Tears, Tear Lipids and Tear Film Dynamics". Dry eye disease (DED) is pervasive with some reports estimating over 16 million adults diagnosed in the United States. Currently, artificial tears remain an integral part of managing dry eyes and are mainly used for symptomatic relief. Recent studies have shown there may be therapeutic benefits with...
What is the current status of trial NCT05705518?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2023-01-30. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT05705518?
The interventions under investigation include: Systane Complete PF (DRUG), Refresh Relieva PF (DRUG), Refresh Optive Mega-3 PF (DRUG), CVS Health Lubricant Eye Drop (PG 0.6%) (DRUG).
Who is sponsoring clinical trial NCT05705518?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.